Autoantibody against aquaporin-5 may be a new diagnostic biomarker for primary Sjögren's syndrome
- PMID: 39441465
- PMCID: PMC11582186
- DOI: 10.1007/s10067-024-07190-1
Autoantibody against aquaporin-5 may be a new diagnostic biomarker for primary Sjögren's syndrome
Abstract
The study aims to assess the diagnostic and clinical significance of autoantibodies against aquaporin-1 (anti-AQP1) and aquaporin-5 (anti-AQP5) in primary Sjögren's syndrome (pSS). A total of 163 participants were categorized into three groups: pSS group, other connective tissue diseases (CTD) group, and healthy control (HC) group. The levels of anti-AQP1 and anti-AQP5 autoantibodies in serum were determined using enzyme-linked immunosorbent assay (ELISA), and clinical data from patients were collected for statistical analysis. Our results showed that the level of anti-AQP1 in the pSS group was higher than in the HC group (P < 0.05), and no significant difference was observed between the pSS group and the CTD group (P > 0.05). ROC showed that the anti-AQP1 had no diagnostic value for pSS (P > 0.05). The anti-AQP5 level of 39 healthy adults was all below the cut-off value (14.10 ng/ml) (P < 0.05). The level of anti-AQP5 in the pSS group was higher than the CTD group (P < 0.05), the AUC was 0.86 (95% CI 0.80-0.93), with a sensitivity of 0.95 (95% CI 0.87-0.99) and a specificity of 0.70 (95% CI 0.58-0.84). No correlation was found between anti-AQP5 levels and the EULAR primary Sjögren's syndrome disease activity index score, anti-SSA, anti-SSB, antinuclear antibodies, rheumatoid factor, anti-ds-DNA, salivary gland flow rate, complement 3, and lymphocyte count in pSS samples (P > 0.05), respectively. Therefore, the elevated anti-AQP5 may emerge as a novel diagnostic biomarker for pSS patients due to high sensitivity and specificity.
Keywords: Anti-aquaporin autoantibody; Biomarker; Primary Sjögren’s syndrome.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study was granted approval by the Ethics Committee of the First Affiliated Hospital of Army Medical University (No: (A) KY2021075). Informed consent was obtained from all the patients before conducting the study. Disclosures: None.
Figures


Similar articles
-
[Diagnostic values of anti-salivary gland protein-1 antibody combined with anti-parotid secretory protein antibody for Sjögren's syndrome].Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Oct 18;56(5):845-852. doi: 10.19723/j.issn.1671-167X.2024.05.015. Beijing Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 39397464 Free PMC article. Chinese.
-
Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome.Oncotarget. 2017 Feb 28;8(9):14306-14313. doi: 10.18632/oncotarget.14882. Oncotarget. 2017. PMID: 28147328 Free PMC article.
-
Anti-aquaporin-5 and anti-poly-U-binding-factor-60kDa protein antibodies in primary Sjögren's disease patients: preliminary data and correlation with disease activity indices.Clin Exp Rheumatol. 2024 Dec;42(12):2420-2426. doi: 10.55563/clinexprheumatol/ku7y1q. Epub 2024 Dec 19. Clin Exp Rheumatol. 2024. PMID: 39699867
-
The meaning of anti-Ro and anti-La antibodies in primary Sjögren's syndrome.Autoimmun Rev. 2011 Jan;10(3):123-5. doi: 10.1016/j.autrev.2010.09.001. Epub 2010 Sep 15. Autoimmun Rev. 2011. PMID: 20833272 Review.
-
Autoantibodies, detection methods and panels for diagnosis of Sjögren's syndrome.Clin Immunol. 2017 Sep;182:24-29. doi: 10.1016/j.clim.2017.03.017. Epub 2017 Apr 5. Clin Immunol. 2017. PMID: 28390965 Review.
References
-
- Manfrè V, Chatzis LG, Cafaro G, Fonzetti S, Calvacchi S, Fulvio G et al (2022) Sjögren’s syndrome: one year in review 2022. Clin Exp Rheumatol 40(12):2211–2224. 10.55563/clinexprheumatol/43z8gu - PubMed
-
- Zhang W, Chen Z, Li XM, Gao J, Zhao Y (2023) Recommendations for the diagnosis and treatment of Sjögren’s syndrome in China. Zhonghua Nei Ke Za Zhi 62(9):1059–1067 - PubMed
-
- Brito-Zerón P, Acar-Denizli N, Ng WF, Zeher M, Rasmussen A, Mandl T, et al (2018) How immunological profile drives clinical phenotype of primary Sjögren’s syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project). Clin Exp Rheumatol.36 Suppl 112(3):102–112. - PubMed
-
- Cornec D, Jousse-Joulin S, Pers JO, Marhadour T, Cochener B, Boisramé-Gastrin S et al (2013) Contribution of salivary gland ultrasonography to the diagnosis of Sjögren’s syndrome: toward new diagnostic criteria? Arthritis Rheum 65(1):216–225. 10.1002/art.37698 - PubMed
-
- He J, Jiang J, Baumgart K (2022) Candidate autoantibodies for primary Sjögren’s syndrome: where are they now? Clin Exp Rheumatol 40(12):2387–2394. 10.55563/clinexprheumatol/vmqtz4 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials